The 25th Annual Meeting of The Sexual Medicine Society of North America (SMSNA) at the AUA will take place on Friday May 18, 2018 at the San Francisco Hilton in San Francisco, California from 8 a.m. to 5 p.m. The program will start with the female sexual dysfunction (FSD) session, moderated by Drs. Ashley Tapscott and Stanley Althof, both experts in the field. Dr. Annamaria Giraldi will provide a 20-year retrospective on the strides and setbacks in the field of female sexual dysfunction and Dr. Sharon Parish will speak on the treatment of female hypoactive sexual desire disorder (HSDD). Female arousal disorder, female orgasmic disorder, sexual pain disorder and HSDD all fall under the umbrella of FSD with the latter affecting nearly 10% of women suffering from sexual dysfunction. .
Dr. Alan Shindel and Michael Eisenberg will speak on the epidemiology and diagnosis of human papilloma virus (HPV) infections in the sexually transmitted section of the program. Dr. Joel Palefsky, an internationally renowned authority in HPV research and the Chair of the HPV Working Group of the AMC, will address HPV related cancers of the genitalia, anus and oropharynx at the session on sexually transmitted infections moderated by Drs. Ira Sharlip and Luiz Otavio Torres, both Past Presidents of the International Society of Sexual Medicine (ISSM). Dr. Palefsky has extensive experience in studying the biology of the HPV infection, HPV vaccines, and clinical trials on this topic. Infection related cancers are a major challenge affecting a significant proportion of all malignancies worldwide. Reflecting the magnitude of the problem, HPV was deemed to be the causative factor in 4.8% of the estimated 12.8 million new cancers occurring worldwide in 2008. .
The State of the Art lectures will be moderated by Drs. Hellstrom and Mulhall, both SMSNA past presidents, and start with a talk by Dr. Allen Morey on the urethral complications of penile fracture. Next Dr. David Ralph will present his talk: “Uncommon but not Unimportant – Diagnosis and Management of Penile Suspensory Ligament Injury.” Dr. Ralph is a leading expert on the topic and has been instrumental in raising awareness and teaching other surgeons (including this author) about this injury. Dr. Mohit Khera, SMSNA Secretary, will deliver a talk on testosterone replacement therapy: “Counseling Patients Prior to Testosterone Replacement Therapy: Are You in Compliance?” Given the controversies and the FDA drug safety communications regarding testosterone labeling requirements, this is an especially important and timely presentation that will also coincide with the release of the AUA Guidelines on Testosterone therapy in May 2018. To follow, a lecture on the opioids and sexual function by the author will highlight some of the key concepts related to this devastating national epidemic pertinent to urologists and sexual/reproductive medicine health care providers. According to the National Safety Council, 99% of physicians prescribe highly addictive opioids longer than the 3 day period recommended by the CDC and 74% have an erroneous belief that the opioids morphine and oxycodone are the most effective means of pain relief. .
Dr. Gerald Brock will review the background and SMSNA Position Statement on “Restorative Therapies” for sexual function. In the last session before the lunch symposium moderated by Drs. Lawrence Hakim and Serge Carrier, Dr. Run Wang, SMSNA President, will deliver the Annual Ira Sharlip Lecture: “From Orient to Occident: Comparison and Contrast. Observations and Reflections in Sexual Medicine.”
Following a 1 hour sponsored lunch symposium, the afternoon session will start with the medical and hormonal therapy session moderated by Drs. Gregory Broderick and Andrew McCullough. The session features talks by Drs. Martin Miner (Exercise and Sexual Health, Is There Really a Correlation?), Faysal Yafi (Diet and Sexual Health), and Ranjith Ramasamy who will present a summary of the randomized trials on shockwave therapy for sexual dysfunction.
The basic science segment of the 2018 program includes a talk by Dr. Kelvin Davies on new molecular targets for cavernous nerve generation in prostate cancer patients as well as a lecture by Dr. Arthur Burnett, SMSNA Past President, aptly titled: “Basic Science in Sexual Medicine: What the Clinician Needs to Know - New Developments and Future Research.”
The psychological considerations in provision of sexual health care to the cancer patient is another highlight of the 2018 SMSNA program. Moderated by renowned psychologists and SMSNA members, Drs. Christian Nelson and Michael Perelman, the program is divided into talks pertaining to bladder cancer (Trinity Bivalacqua), Prostate Cancer (Daniela Wittman) and Breast Cancer (Sharon Bober).
The Peyronie’s Disease program is moderated by Drs. Culley Carson and Ronald Lewis and includes talks by Drs. Tom Lue: “When Plaque Becomes Bone: A Lesson in Histopathology”, Landon Trost: “Xiaflex On-Label and Off-Label Intralesional Protocols”, and William Brant: “Remodeling and Lengthening Techniques in Peyronie’s Disease.”
Planned as a collaborative effort by the Society of Urologic Prosthetic Surgeons (SUPS) and SMSNA, the surgical session will be co-moderated by the President Elects of each society (Rafael Carrion and Hossein Sadeghi-Nejad) and start with a talk/dialogue amongst 3 of the most widely recognized prosthetic surgeons in the world (Drs. John Mulcahy, Drogo Montague, Steven Wilson) titled: “Road map for the new generation of prosthetic surgeons: A Few Things We Learned Along the Way - Q&A Among Experts.”
The SUPS Lecture on urinary incontinence in the age of robotic prostatectomy will be delivered by Dr. LeRoy Jones, SUPS President. This will then be followed with a talk by Dr. Thomas Walsh on the use of surgical simulators for teaching prosthetic surgery. Drs. Paul Perito and Gerard Henry, high volume implanters with years of expertise in the field, will educate the audience on their tactics as experienced surgeons for avoiding adverse events in the most challenging cases, while Drs. Tobias Kohler and Brian Christine will outline the strengths and advantages of various prosthetic devices in different clinical scenarios. Finally, the scientific session will conclude with talks by Dr. Maurice Garcia speaking on challenges to quality outcome measures in transgender surgery and Dr. Irwin Goldstein addressing surgical aspects of female sexual dysfunction therapy. Both Drs. Garcia and Goldstein are internationally recognized names in and are certain to provide the audience with the latest state-of-the-art information on their respective topics and areas of expertise.
SMSNA, providing a forum for the free exchange and discussion of new ideas, thoughts and concepts in this field, strives to promote the highest standards of practice, research, education, and ethics in the study of all aspects of human sexual function and dysfunction. We encourage all practitioners with an interest in sexual medicine to attend this very exciting meeting.
- The pathophysiology of hypoactive sexual desire disorder in women. Clayton AH. Int J Gynaecol Obstet. 2010 Jul; 110(1):7-11.
- Comprehensive control of human papillomavirus infections and related diseases. Bosch FX1, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. 2013 Nov 22;31 Suppl 8:I1-31.
- NSC Poll: 99% of Doctors Prescribe Highly-addictive Opioids Longer Than CDC Recommends. National Safety Council. March 24, 2016
We look forward to seeing you in San Francisco.
Hossein Sadeghi-Nejad, MD, FACS